Ann: Pharmaceutical Clinical Study Commences, page-34

Rebel1, market isn't yawning or asleep. OBJ is what it is. It's management, lack of clarity, income and consistently setting timelines to which they consistently fail to met ( or never mention again). Look how they play the share holder by putting three milestones forward of which the first two are primarily to their benefit and then dangle the magic $20 million 3rd milestone which would benefit every share holder ( and would not be voted down at the AGM ) . What do you have today? A depressed share price, no interest by the market, cornerstone investor? Nope? Just as last year, a flurry of 'market updates' to excite the holders before the love fest of the AGM. Well not this year. How embarrassing as a company to respond to todays ASX please explain.... good look wasn't it?
Someone asked what the next OBJ announcement might be? How about someone walking the plank for a change. I bet you $0.045 that it would bump up the share price.